| Felix Gold Limited (FXG) ORDINARY FULLY PAID |
Materials |
$58 |
Notice of General Meeting/Proxy Form
|
19 May 2025 10:44AM |
$0.145 |
$0.140 |
fallen by
3.45%
|
|
| Way 2 Vat Ltd (W2V) ORDINARY FULLY PAID |
Information Technology |
$12 |
Notification regarding unquoted securities - W2V
|
19 May 2025 10:43AM |
$0.007 |
$0.007 |
fallen by
0%
|
|
| ImExHS Limited (IME) ORDINARY FULLY PAID |
Health Care |
$16 |
AGM - Chairman & CEO Addresses and Presentation
|
19 May 2025 10:37AM |
$0.330 |
$0.295 |
fallen by
10.61%
|
|
IME - Price-sensitive ASX Announcement
Full Release
Key Points
- Chairman and CEO deliver addresses at the ImExHS Limited AGM.
- Overview of operational performance and strategic direction.
- Highlights of recent achievements and progress in product innovation.
- Challenges faced by the company and responses implemented.
- Emphasis on financial performance, cost management, and shareholder value.
- Continued focus on medical imaging technology and healthcare solutions.
- Plans for future growth, expansion, and market opportunities.
- Acknowledgments to staff, partners, and shareholders for their support.
- Commitment to ongoing operational efficiency improvements.
- Strategic initiatives to drive sustainable growth and innovation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Urbanise.Com Limited (UBN) ORDINARY FULLY PAID |
Information Technology |
$67 |
Notice under Section 708A(5)(e) of the Corporations Act
|
19 May 2025 10:36AM |
$0.800 |
$0.850 |
risen by
6.25%
|
|
| Select Harvests Limited (SHV) ORDINARY FULLY PAID |
Consumer Staple |
$583 |
Notification regarding unquoted securities - SHV
|
19 May 2025 10:32AM |
$4.880 |
$4.100 |
fallen by
15.98%
|
|
| Urbanise.Com Limited (UBN) ORDINARY FULLY PAID |
Information Technology |
$67 |
Application for quotation of securities - UBN
|
19 May 2025 10:32AM |
$0.800 |
$0.850 |
risen by
6.25%
|
|
| Adherium Limited (ADR) ORDINARY FULLY PAID |
Health Care |
$5 |
$900K Capital Raise to Accelerate Smart Inhaler in US
|
19 May 2025 10:31AM |
$0.007 |
$0.006 |
fallen by
14.29%
|
|
ADR - Price-sensitive ASX Announcement
Full Release
Key Points
- Adherium Limited announced a $900,000 capital raise.
- Funds will accelerate the Hailie® Smartinhaler™ commercialisation in the US.
- The raise is via a placement to sophisticated and professional investors.
- Primary use of funds: US market expansion, product development, regulatory activities.
- Focus on digital respiratory health, medication adherence, and disease management.
- Strong clinical evidence supports the Smartinhaler™ technology.
- Adherium is engaging with payers and partners in the US.
- Placement strengthens Adherium’s position in the US digital health market.
- Strategic emphasis on asthma and COPD management.
- Details provided on allocation of capital and next steps for US operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Blue Star Helium Limited (BNL) ORDINARY FULLY PAID |
Energy |
$13 |
Notification of cessation of securities - BNL
|
19 May 2025 10:29AM |
$0.007 |
$0.005 |
fallen by
28.57%
|
|
| Nutritional Growth Solutions Ltd (NGS) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
Change in substantial holding
|
19 May 2025 10:29AM |
$0.026 |
$0.023 |
fallen by
11.54%
|
|
| HeraMED Limited (HMD) ORDINARY FULLY PAID |
Health Care |
$6 |
Customer Update & US Market Strategy
|
19 May 2025 10:29AM |
$0.019 |
$0.007 |
fallen by
63.16%
|
|
HMD - Price-sensitive ASX Announcement
Full Release
Key Points
- HeraMED Limited (HeraMED or the Company) provides an update regarding its customer pipeline and strategic focus on the US market.
- The Company has experienced delays in revenue realisation from existing contracts, particularly with Sheba Medical Center and Joondalup Health Campus, due to slower-than-expected implementations.
- A new partnership agreement has been signed with HMC Group to expand the commercialisation of HeraCARE in the US market.
- HeraMED is focusing on commercialising its remote monitoring and maternity care solutions in the US, where there is high demand for maternal health support and digital health innovation.
- The Company’s US go-to-market strategy includes targeting private healthcare providers, insurers, and strategic partners to accelerate adoption.
- The update acknowledges that while existing contracts are progressing, revenue uptake has lagged behind initial expectations, hence the increased focus on US opportunities.
- HeraMED has a robust sales pipeline and continues to pursue further contracts and pilot programs with healthcare organisations globally.
- The Company is implementing measures to manage cash flow and reduce costs in the interim period to ensure ongoing operations.
- The Board remains confident in the long-term commercial potential of HeraMED’s technology and its ability to benefit from structural shifts in healthcare delivery, especially in the US.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Urbanise.Com Limited (UBN) ORDINARY FULLY PAID |
Information Technology |
$67 |
Update - Application for quotation of securities - UBN
|
19 May 2025 10:27AM |
$0.800 |
$0.850 |
risen by
6.25%
|
|
| Staude Capital Global Value Fund Limited (GVF) ORDINARY FULLY PAID |
Financials |
$258 |
GVF Investor Presentation May 2025
|
19 May 2025 10:25AM |
$1.345 |
$1.375 |
risen by
2.23%
|
|
| Eureka Group Holdings Limited (EGH) ORDINARY FULLY PAID |
Real Estate |
$252 |
Notification regarding unquoted securities - EGH
|
19 May 2025 10:21AM |
$0.530 |
$0.595 |
risen by
12.26%
|
|
| Peoplein Limited (PPE) ORDINARY FULLY PAID |
Industrials |
$79 |
Ceasing to be a substantial holder
|
19 May 2025 10:21AM |
$0.715 |
$0.725 |
risen by
1.40%
|
|
| Argenica Therapeutics Limited (AGN) ORDINARY FULLY PAID |
Health Care |
$95 |
Investor Presentation
|
19 May 2025 10:19AM |
$0.750 |
$0.740 |
fallen by
1.33%
|
|
| Enlitic Inc (ENL) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$21 |
Notice of Annual General Meeting/Proxy Form
|
19 May 2025 10:16AM |
$0.032 |
$0.025 |
fallen by
21.88%
|
|
| Axel REE Limited (AXL) ORDINARY FULLY PAID |
Materials |
$8 |
Cleansing Notice - Options
|
19 May 2025 10:14AM |
$0.070 |
$0.083 |
risen by
18.57%
|
|
| Axel REE Limited (AXL) ORDINARY FULLY PAID |
Materials |
$8 |
Application for quotation of securities - AXL
|
19 May 2025 10:10AM |
$0.070 |
$0.083 |
risen by
18.57%
|
|
| Volt Resources Limited (VRC) ORDINARY FULLY PAID |
Materials |
$19 |
Trading Halt
|
19 May 2025 10:09AM |
$0.005 |
$0.004 |
fallen by
20%
|
|
VRC - Price-sensitive ASX Announcement
Full Release
Key Points
- Volt Resources Limited requested a trading halt from the ASX.
- The trading halt is pending an announcement about a capital raising.
- The company sought the halt to ensure orderly trading and prevent uninformed trading.
- The trading halt was to last until either the capital raising announcement or the start of normal trading on December 6, 2023.
- Volt Resources Limited confirmed it was not aware of any reason the halt should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Emu NL (EMU) ORDINARY FULLY PAID |
Materials |
$4 |
EGM Voting Results
|
19 May 2025 10:06AM |
$0.024 |
$0.019 |
fallen by
20.83%
|
|
EMU - Price-sensitive ASX Announcement
Full Release
Key Points
- The document is the official voting results of the Emu NL 2022 Annual General Meeting.
- It reports the outcomes for a series of resolutions, including director re-election, remuneration report, performance rights approvals, and share issue ratifications.
- Each resolution lists the number and percentage of votes cast for and against, as well as abstentions and proxies.
- All resolutions put to vote were carried (i.e., passed by shareholders).
- Details include ordinary and special resolutions, and the relevant sections of the Corporations Act.
- The report outlines any votes that were excluded or not counted under relevant regulations.
- The meeting was conducted with appropriate disclosure of voting instructions and results in accordance with legal and governance requirements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Uvre Limited (UVA) ORDINARY FULLY PAID |
Materials |
$6 |
Proposed issue of securities - UVA
|
19 May 2025 10:06AM |
$0.094 |
$0.099 |
risen by
5.32%
|
|
| Uvre Limited (UVA) ORDINARY FULLY PAID |
Materials |
$6 |
Acquisition and Equity Raise Presentation
|
19 May 2025 10:05AM |
$0.094 |
$0.099 |
risen by
5.32%
|
|
UVA - Price-sensitive ASX Announcement
Full Release
Key Points
- Uvre Limited proposes acquiring the East Canyon Uranium-Vanadium Project in Utah, USA.
- The acquisition aims to establish Uvre as a significant uranium and vanadium explorer.
- East Canyon Project has established uranium-vanadium mineralization and historical workings.
- The area is supported by existing infrastructure and is situated in a mining-friendly jurisdiction.
- Geological mapping, sampling, and drilling have highlighted significant exploration upside.
- Uvre plans to raise equity capital to fund the acquisition and exploration activities.
- The uranium market is experiencing renewed interest due to energy security and decarbonization trends.
- Uvre's strategy is to advance exploration, define resources, and create shareholder value.
- The presentation outlines the transaction structure, use of funds, and indicative timeline.
- The management and board have experience in resource project development and capital markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Uvre Limited (UVA) ORDINARY FULLY PAID |
Materials |
$6 |
Transformational NZ Gold Projects Acquisition
|
19 May 2025 10:05AM |
$0.094 |
$0.099 |
risen by
5.32%
|
|
UVA - Price-sensitive ASX Announcement
Full Release
Key Points
- Uvre Limited (UVA) enters binding agreement to acquire 100% of Trans-Tasman Gold Holdings Ltd (TTGH).
- TTGH holds three major gold projects in New Zealand: Longwood Range, Waikaia, and Marlborough.
- Acquisition diversifies UVA’s portfolio beyond uranium and rare earths into gold.
- Consideration involves issue of UVA shares and performance rights, requiring shareholder approval.
- Historical gold production recorded in the acquired project areas.
- Company plans further exploration, drilling, and resource definition at the new projects.
- Acquisition aligns with UVA’s strategy to enhance growth and exposure to precious metals.
- The transaction is subject to conditions precedent including due diligence and regulatory approvals.
- UVA board views the acquisition as transformational for the company’s future.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Volt Resources Limited (VRC) ORDINARY FULLY PAID |
Materials |
$19 |
Pause in Trading
|
19 May 2025 10:02AM |
$0.005 |
$0.004 |
fallen by
20%
|
|
VRC - Price-sensitive ASX Announcement
Full Release
Key Points
- Volt Resources Limited (VRC) requested a voluntary pause in trading of its securities on the ASX.
- The trading halt commenced on 29 December 2023.
- The halt is pending an announcement regarding a material transaction.
- The trading pause aims to ensure an orderly market.
- The halt will remain until the earlier of a new announcement or normal trading on 2 January 2024.
- Volt is not aware of any reason the halt should not be granted.
- No other information is required to be disclosed to the market about the pause.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MedAdvisor Limited (MDR) ORDINARY FULLY PAID |
Health Care |
$51 |
Application for quotation of securities - MDR
|
19 May 2025 10:02AM |
$0.088 |
$0.081 |
fallen by
7.95%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
